Owens & Minor has closed the previously announced acquisition of Apria, Inc. The acquisition was consummated for total consideration in cash of approximately $1.6 billion. The purchase was funded with a combination of debt and cash on hand.
The combined entity will create a broad portfolio of complementary products to service patients with chronic and non-chronic conditions, and an expanded product delivery and distribution model. Apria will be combined with Owens & Minor’s existing Byram Healthcare business to form the new Patient Direct segment.